A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. (Q45739549)
Jump to navigation
Jump to search
scientific article published in November 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. |
scientific article published in November 2000 |
Statements
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme (English)
Rainov NG
1 reference
1 November 2000